Key Dates

Related Announcements

PAR-20-225 - Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional)

NOT-DA-20-075 - Notice of Correction to PAR-20-225, "Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional)"

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

This Notice is to inform potential applicants of an error in the Notice of Correction, NOT-DA-20-075 "Notice of Correction to PAR-20-225, "Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional)" from the funding opportunity announcement PAR-20-225, "Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional)".

NOT-DA-20-075 incorrectly listed the five-year total direct cost as $3.5 million. The five-year total direct cost listed in PAR-20-225 is correct at $1.5 million. Applications must request no more than $300,000 direct costs per year for up to five years with a five-year total direct cost limit of $1.5 million.

The intended correction in NOT-DA-20-075 noting that a detailed budget is not requested and will not be accepted is correct. PAR-20-225 does not allow for and will not accept a detailed budget.

In light of this error, NIDA will extend the application due date for the October 19,2020 submission date. The new application due date is: November 2, 2020.

Currently reads:

Open Date (Earliest Submission Date): September 19, 2020

Letter of Intent Due Date(s): 30 days prior to the application due date

Application Due Date(s): October 19, 2020, October 19, 2021, October 19, 2022 by 5:00 PM local time of applicant organization.

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Modified to read:

Open Date (Earliest Submission Date): September 19, 2020

Letter of Intent Due Date(s): 30 days prior to the application due date

Application Due Date(s): November 2, 2020, October 19, 2021, October 19, 2022 by 5:00 PM local time of applicant organization.

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Currently reads:

Section IV. Application and Submission Information

Note: The Budget Request is entered only in the fields for "Total Federal Funds Requested" and "Total Federal & Non-Federal Funds" as described above. Funds may be requested for personnel (including collaborators), supplies, equipment, sub-contracts, and other allowable costs. Only the five-year total - $3.5 million - should be entered in the fields for "Total Federal Funds Requested" and "Total Federal & Non-Federal Funds". Applicable Facilities and Administrative (F&A) costs will be determined at the time of award and should not be included in the budget request.

Modified to read:

Section IV. Application and Submission Information

Note: The Budget Request is entered only in the fields for "Total Federal Funds Requested" and "Total Federal & Non-Federal Funds" as described above. Funds may be requested for personnel (including collaborators), supplies, equipment, sub-contracts, and other allowable costs. Only the five-year total - $1.5 million - should be entered in the fields for "Total Federal Funds Requested" and "Total Federal & Non-Federal Funds". Applicable Facilities and Administrative (F&A) costs will be determined at the time of award and should not be included in the budget request.

The following instructions are clarified:

(Sections below will be deleted)

R&R Budget

All instructions in the SF424 (R&R) Application Guide must be followed.

R&R Subaward Budget

All instructions in the SF424 (R&R) Application Guide must be followed.

 Modified to read:

R&R Budget: This form is not provided and must not be submitted.

R&R Subaward Budget: This form is not provided and must not be submitted.

All other aspects of the FOA and NOT-DA-20-075 remain the same.

Inquiries

Please direct all inquiries to:

Jonathan D. Pollock, Ph.D.
National Institute on Drug Abuse
Telephone: 301-435-1309
Email:jpollock@mail.nih.gov

John Satterlee, Ph.D.
National Institute on Drug Abuse
Telephone: 301-435-1020
Email:satterleej@nida.nih.gov